Lumos Diagnostics Holdings Management
Management criteria checks 3/4
Lumos Diagnostics Holdings' CEO is Doug Ward, appointed in Jun 2022, has a tenure of 2.58 years. total yearly compensation is $773.94K, comprised of 62.7% salary and 37.3% bonuses, including company stock and options. directly owns 0.43% of the company’s shares, worth $75.85K. The average tenure of the management team and the board of directors is 3 years and 4.1 years respectively.
Key information
Doug Ward
Chief executive officer
US$773.9k
Total compensation
| CEO salary percentage | 62.7% |
| CEO tenure | 2.6yrs |
| CEO ownership | 0.4% |
| Management average tenure | 3yrs |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | US$774k | US$485k | -US$9m |
| Mar 31 2024 | n/a | n/a | -US$9m |
| Dec 31 2023 | n/a | n/a | -US$9m |
| Sep 30 2023 | n/a | n/a | -US$9m |
| Jun 30 2023 | US$665k | US$415k | -US$9m |
| Mar 31 2023 | n/a | n/a | -US$25m |
| Dec 31 2022 | n/a | n/a | -US$41m |
| Sep 30 2022 | n/a | n/a | -US$43m |
| Jun 30 2022 | US$472k | US$14k | -US$46m |
Compensation vs Market: Doug's total compensation ($USD773.94K) is about average for companies of similar size in the US market ($USD649.25K).
Compensation vs Earnings: Doug's compensation has increased whilst the company is unprofitable.
CEO
Doug Ward
2.6yrs
Tenure
US$773,939
Compensation
Mr. Douglas Ward, also known as Doug, serves as Chief Executive Officer of Lumos Diagnostics Holdings Limited since June 20, 2022 and its Managing Director and Director since July 13, 2023. He was Chief Ex...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Director | 2.6yrs | US$773.94k | 0.43% $ 75.8k | |
| Chief Financial Officer | 2.9yrs | US$385.34k | no data | |
| Chief Technology Officer | no data | no data | no data | |
| Vice President of Corporate Marketing & Communications | 4yrs | no data | no data | |
| Senior Director of Human Resources | 4.1yrs | no data | no data | |
| Senior Vice President of Commercial Operations | 3yrs | no data | no data | |
| Company Secretary | no data | no data | no data |
3.0yrs
Average Tenure
Experienced Management: LDXH.F's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Director | 1.5yrs | US$773.94k | 0.43% $ 75.8k | |
| Non-Executive Chairman | 6yrs | US$182.78k | 0.18% $ 32.2k | |
| Independent Director | 4.2yrs | US$65.51k | 0.023% $ 4.1k | |
| Independent Director | 4.1yrs | US$61.88k | 0.28% $ 48.9k | |
| Strategic Healthcare Adviser & Member of Medical Advisory Board | 3.3yrs | no data | no data |
4.1yrs
Average Tenure
Experienced Board: LDXH.F's board of directors are considered experienced (4.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 10:32 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Lumos Diagnostics Holdings Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Elyse Shapiro | Bell Potter |
| Shane Storey | Wilsons Advisory and Stockbroking Ltd. |